Cultivation of filamentous fungi in airlift bioreactors: advantages and disadvantages
Applied Microbiology and Biotechnology · 10.02.2025 · 109 (1)
DOI: 10.1007/s00253-025-13422-4 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Applied Microbiology and Biotechnology, online erschienen am 10.02.2025. Verfasst von Federico Cerrone und 1 weiteren Autor:innen. Beteiligte Einrichtung: School of Biotechnology, Dublin City University, Glasnevin Campus Dublin, Dublin, Ireland. Federico.cerrone@dcu.ie. Hauptthemen laut MEDLINE: Bioreactors, Fungi. Die Arbeit wurde bisher 40-mal zitiert (Crossref) und nennt 145 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Dublin City University.
Abstract (Originalsprache)
Filamentous fungi or mycelia are a valuable bioresource to produce several biomolecules and enzymes, especially because of their biodegradation potential and for their key role of enablers of a circular bioeconomy. Filamentous fungi can be grown in submerged cultivation to maximise the volumetric productivity of the bioprocess, instead of using the more established and time-consuming solid-state cultivation. Multicellular mycelia are sensitive to shear stresses induced by mechanical agitation, and this aspect greatly affects their morphology in submerged cultivation (pelletisation) and the connected volumetric productivity. An efficient compromise is the growth of filamentous fungi in airlift bioreactors (ALR) where the volumetric oxygen transfer (K L a) is optimal, but the shear stress is reduced. In this review, we critically analysed the advantages and disadvantages of ALR-based cultivation of filamentous fungi, comparing these bioreactors also with stirred tank reactors and bubble column reactors; we focused on scientific literature that highlights findings for the cultivation of filamentous fungi for both the production of enzymes and the production of myco-biomass in ALR; we included studies for the control of the pelletisation of the fungal biomass in batch and semi-continuous cultivation, highlighting the interlinked hydrodynamics; finally, we included studies regarding the modifications of ALR in order to enhance filamentous fungi production. Key points • ALR are efficient for batch and prolonged continuous cultivation of filamentous fungi. • ALR show both optimal gas hold-up and K L a with an airflow that has high superficial velocity and critical bubble diameter (1–6 mm). • Suspended mycelia aggregates (pellet) maintain a fluidised motion in ALR if their size/density can be controlled.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Biotechnology, Dublin City University, Glasnevin Campus Dublin, Dublin, Ireland. Federico.cerrone@dcu.ie.
- BiOrbic Bioeconomy Research Centre, O'Brien Centre for Science (Science East) University College Dublin, Belfield Campus Dublin, Dublin, Ireland. Federico.cerrone@dcu.ie.
- BiOrbic Bioeconomy Research Centre, O'Brien Centre for Science (Science East) University College Dublin, Belfield Campus Dublin, Dublin, Ireland.
- School of Biomolecular and Biomedical Sciences, University College Dublin, Belfield Campus Dublin, Dublin, Ireland.
- Bioplastech Ltd NovaUCD, Belfield Innovation Park, University College Dublin, Dublin, Ireland.
Förderung
- Dublin City University
Zitieren
APA
Cerrone, F., & O'Connor, K. E. (2025). Cultivation of filamentous fungi in airlift bioreactors: advantages and disadvantages. Applied Microbiology and Biotechnology, 109(1). https://doi.org/10.1007/s00253-025-13422-4
Vancouver
Cerrone F, O'Connor KE. Cultivation of filamentous fungi in airlift bioreactors: advantages and disadvantages. Applied Microbiology and Biotechnology. 2025;109(1). doi:10.1007/s00253-025-13422-4
BibTeX
@article{Cerrone2025,
author = {Cerrone, Federico and O'Connor, Kevin E},
title = {Cultivation of filamentous fungi in airlift bioreactors: advantages and disadvantages},
journal = {Applied Microbiology and Biotechnology},
year = {2025},
volume = {109},
number = {1},
doi = {10.1007/s00253-025-13422-4}
}
EUVIMED